{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T17:01:02Z","timestamp":1758474062986,"version":"3.37.0"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"858","license":[{"start":{"date-parts":[[1997,4,1]],"date-time":"1997-04-01T00:00:00Z","timestamp":859852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1997,4,1]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>The use of long-acting and potent somatostatin analogues is a major advance in the management of carcinoid tumours. In addition to providing effective symptom relief in malignant carcinoid syndrome, octreotide can also be used for diagnostic purposes. Despite its expense, octreotide is the current agent of choice for the treatment of this condition while analogues with different receptor specificities and pharmacokinetics hold promise for the future. Gastric carcinoids have aroused interest because of their experimental association with chronic hypergastrinaemia, a condition now commonplace because of the widespread use of H2-blockers and proton-pump inhibitors. This subject is reviewed. The slow evolution of many tumours demands prolonged follow-up and the active use of a variety of palliative interventions. These include measures such as hepatic and cardiac surgery, which might be deemed inappropriate for patients with other types of metastatic malignancy. Interferons may have a role when first-line treatments have failed. Chemotherapy is, generally, of limited value.<\/jats:p>","DOI":"10.1136\/pgmj.73.858.207","type":"journal-article","created":{"date-parts":[[2008,12,29]],"date-time":"2008-12-29T21:49:00Z","timestamp":1230587340000},"page":"207-214","source":"Crossref","is-referenced-by-count":18,"title":["Carcinoid tumours"],"prefix":"10.1093","volume":"73","author":[{"given":"S","family":"Janmohamed","sequence":"first","affiliation":[{"name":"Francis Fraser Laboratories, Department of Endocrinology, Royal Postgraduate Medical School , Du Cane Road, London W12 0NN, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S R","family":"Bloom","sequence":"additional","affiliation":[{"name":"Francis Fraser Laboratories, Department of Endocrinology, Royal Postgraduate Medical School , Du Cane Road, London W12 0NN, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[1997,4,1]]},"reference":[{"key":"ref_1","first-page":"560","article-title":"Carcinoid tumours. An analysis of 2,837 cases","volume":"36","author":"Godwin, II, J.D.","year":"1975","unstructured":"Godwin JD, II. Carcinoid tumours. An analysis of 2,837 cases. Cancer 1975; 36: 560-9.","journal-title":"Cancer"},{"key":"ref_2","first-page":"795","article-title":"Bronchial carcinoid tumours","volume-title":"Mayo Clin Proc","volume":"68","author":"Davila, D.G.; Dunn, W.F.; Tazelaar, H.D.; Pairolero, P.G.","year":"1993","unstructured":"Davila DG, Dunn WF, Tazelaar HD, Pairolero PG. Bronchial carcinoid tumours. Mayo Clin Proc 1993; 68: 795-803."},{"key":"ref_3","first-page":"889","article-title":"Growth regulation in carcinoid tumours","volume":"22","year":"1992","unstructured":"Ahlman H, Wangberg B, Nilsson 0. Growth regulation in carcinoid tumours. Endocrinol Metab Clin North Am 1992; 22: 889 - 915.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"ref_4","first-page":"142","article-title":"Carcinoids associated with multiple endocrine neoplasia syndromes","volume":"154","author":"Duh, Q.W.; Hybarger, C.P.; Geist, R.","year":"1987","unstructured":"Duh QW, Hybarger CP, Geist R et al. Carcinoids associated with multiple endocrine neoplasia syndromes. AmJSurg 1987; 154: 142-7.","journal-title":"AmJSurg"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0889-8553(21)00446-5","article-title":"Clinical features, diagnosis, and localization of carcinoid tumours, and their management","volume":"18","author":"Vinik, A.I.; McCleod, M.K.; Fig, L.M.; Shapiro, B.; Lloyd, R.V.; Cho, K.","year":"1989","unstructured":"Vinik AI, McCleod MK, Fig LM, Shapiro B, Lloyd RV, Cho K. Clinical features, diagnosis, and localization of carcinoid tumours, and their management. Gastroenterol Clin North Am 1989; 18: 865-96.","journal-title":"Gastroenterol Clin North Am"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1365-2362.1990.tb01781.x","article-title":"Classification and histogenesis of gastroenteropancreatic endocrine tumours","volume":"1","author":"Solcia, E.; Sessa, F.; Rindi, G.","year":"1990","unstructured":"Solcia E, Sessa F, Rindi G, et al. Classification and histogenesis of gastroenteropancreatic endocrine tumours. Eur J Clin Invest 1990; 20 (Suppl 1): S72-81.","journal-title":"Eur J Clin Invest"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0002-9610(05)80529-X","article-title":"Biology and management of the midgut carcinoid","volume":"165","author":"Basson, M.D.; Ahlman, H.; Wangberg, B.; Modlin, I.M.","year":"1993","unstructured":"Basson MD, Ahlman H, Wangberg B, Modlin IM. Biology and management of the midgut carcinoid. Am Y Surg 1993; 165: 288-97.","journal-title":"Am Y Surg"},{"key":"ref_8","first-page":"459","article-title":"Aspects on diagnosis and treatment of the foregut carcinoid syndrome","volume":"27","author":"true","year":"1992","unstructured":"Ahlman H, Wangberg B, Nilsson 0, et al. Aspects on diagnosis and treatment of the foregut carcinoid syndrome. Lancet 1992; 27: 459-71.","journal-title":"Lancet"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3109\/00365529309101582","article-title":"Recent developments in diagnosis and treatment of metastatic carcinoid tumours","volume":"28","author":"EGE, De Vries; IP, Kema; MJH, Sloof","year":"1993","unstructured":"De Vries EGE, Kema IP, Sloof MJH, et al. Recent developments in diagnosis and treatment of metastatic carcinoid tumours. Scand y Gastroenterol 1993; 28: 87-93.","journal-title":"Scand y Gastroenterol"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000201206","article-title":"Clinical management of gastric carcinoid tumors","volume":"55","author":"Ahlman, H.; Kolby, L.; Lundell, L.","year":"1994","unstructured":"Ahlman H, Kolby L, Lundell L, et al. Clinical management of gastric carcinoid tumors. Digestion 1994; 55: 77-85.","journal-title":"Digestion"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1210\/edrv-12-4-450","article-title":"The role of somatostatin and its analogs in the diagnosis and treatment of tumors","volume":"12","author":"Lamberts, S.W.J.; Krenning, E.P.; Reubi, J.","year":"1991","unstructured":"Lamberts SWJ, Krenning EP, Reubi J. The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocrine Rev 1991; 12: 450-82.","journal-title":"Endocrine Rev"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1056\/NEJM198609113151102","article-title":"Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue","volume":"315","author":"Kvols, L.K.; Moertel, C.G.; O'Connell, M.J.; Schutt, A.J.; Rubin, J.; Hahn, R.G.","year":"1986","unstructured":"Kvols LK, Moertel CG, O'Connell MJ, Schutt AJ, Rubin J, Hahn RG. Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue. N Engl Jf Med 1986; 315: 663-6.","journal-title":"N Engl Jf Med"},{"issue":"575 -6","key":"ref_13","article-title":"Clinical relevance of somatostatin receptor imaging","volume":"131","author":"Reubi, J.C.","year":"1994","unstructured":"Reubi JC. Clinical relevance of somatostatin receptor imaging. Eur Jf Endocrinol 1994; 131: 575 -6.","journal-title":"Eur Jf Endocrinol"},{"key":"ref_14","first-page":"1","article-title":"Somatostatin and the concept of peptide receptor scintigraphy in oncology","volume":"21","author":"Lamberts, S.W.J.; Reubi, J.; Krenning, E.P.","year":"1994","unstructured":"Lamberts SWJ, Reubi J, Krenning EP. Somatostatin and the concept of peptide receptor scintigraphy in oncology. Semin Oncol 1994; 21: 1-5.","journal-title":"Semin Oncol"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/BF00181765","article-title":"the Rotterdam experience with more than 1000 patients","volume":"20","author":"Krenning, E.P.; Kwekkeboom, D.J.; Bakker, W.H.","year":"1993","unstructured":"Krenning EP, Kwekkeboom DJ, Bakker WH, et al. Somatostatin receptor scintigraphy with [11 lIn-DTPA-D-Phel]-and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur I Nucl Med 1993; 20: 716-31.","journal-title":"Eur I Nucl Med"},{"key":"ref_16","first-page":"577","article-title":"[\"1'In-DTPA-DPhe']Octreotide scintigraphy in patients with carcinoid tumours: the predictive value for somatostatin analogue treatment","volume":"1","author":"Janson, E.T.; Westlin, J.E.; Eriksson, B.; Ahlstrom, H.; Nilsson, S.; Oberg, K.","year":"1994","unstructured":"Janson ET, Westlin JE, Eriksson B, Ahlstrom H, Nilsson S, Oberg K. [\"1'In-DTPA-DPhe']Octreotide scintigraphy in patients with carcinoid tumours: the predictive value for somatostatin analogue treatment. Eur Jf Endocrinol 1994; 1: 577-81.","journal-title":"Eur Jf Endocrinol"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/1097-0142(19910715)68:2<227::AID-CNCR2820680202>3.0.CO;2-I","article-title":"Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms","volume":"68","author":"Moertel, C.G.; Kvols, L.K.; O'Connell, M.J.; Rubin, J.","year":"1991","unstructured":"Moertel CG, Kvols LK, O'Connell MJ, Rubin J. Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms. Cancer 1991; 68: 227-32.","journal-title":"Cancer"},{"key":"ref_18","first-page":"1503","article-title":"An odyssey in the land of small tumors","volume":"5","author":"Moertel, C.G.","year":"1987","unstructured":"Moertel CG. An odyssey in the land of small tumors. Jf Clin Oncol 1987; 5: 1503 - 22.","journal-title":"Jf Clin Oncol"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00004836-199303000-00009","article-title":"Carcinoid tumors of the gut. Our experience over three decades and review of the literature","volume":"16","author":"Marshall, J.B.; Bodnarchuk, G.","year":"1993","unstructured":"Marshall JB, Bodnarchuk G. Carcinoid tumors of the gut. Our experience over three decades and review of the literature. J Clin Gastroenterol 1993; 16: 123-9.","journal-title":"J Clin Gastroenterol"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/02841869309083912","article-title":"Metastatic carcinoid tumors and the malignant carcinoid syndrome","volume":"32","author":"Kvols, L.K.; Reubi, J.","year":"1993","unstructured":"Kvols LK, Reubi J. Metastatic carcinoid tumors and the malignant carcinoid syndrome. Acta Oncol 1993; 32: 197-201.","journal-title":"Acta Oncol"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1148\/radiology.155.3.4001362","article-title":"Control of carcinoid syndrome with hepatic artery embolisation","volume":"155","author":"Mitty, H.A.; Warner, R.R.P.; Newman, L.H.; Trains, J.S.; Pames, I.H.","year":"1985","unstructured":"Mitty HA, Warner RRP, Newman LH, Trains JS, Pames IH. Control of carcinoid syndrome with hepatic artery embolisation. Radiology 1985; 155: 623-6.","journal-title":"Radiology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000201210","article-title":"Liver transplantation for metastatic carcinoid tumors","volume":"55","author":"Frilling, A.; Rogiers, X.; Broelsch, C.E.","year":"1994","unstructured":"Frilling A, Rogiers X, Broelsch CE. Liver transplantation for metastatic carcinoid tumors. Digestion 1994; 55: 104-6.","journal-title":"Digestion"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3109\/02841869109092408","article-title":"Carcinoid heart disease. A cardiologist's point of view","volume":"30","author":"Lundin, L.","year":"1991","unstructured":"Lundin L. Carcinoid heart disease. A cardiologist's point of view. Acta Oncol 1991; 30: 499-502.","journal-title":"Acta Oncol"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00000658-198708000-00001","article-title":"Malignant carcinoid tumors. An analysis of 103 patients with regard to tumor localization, hormone production, and survival","volume":"206","author":"Norheim, I.; Oberg, K.; Theodorsson Norheim, E.","year":"1987","unstructured":"Norheim I, Oberg K, Theodorsson Norheim E, et al. Malignant carcinoid tumors. An analysis of 103 patients with regard to tumor localization, hormone production, and survival. Ann Surg 1987; 206: 115 - 25.","journal-title":"Ann Surg"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/0735-1097(94)00374-Y","article-title":"Outcome of cardiac surgery for carcinoid heart disease","volume":"25","author":"Connolly, H.M.; Nishimura, R.A.; Smith, H.C.; Pellikka, P.A.; Mullany, C.J.; Kvols, L.K.","year":"1995","unstructured":"Connolly HM, Nishimura RA, Smith HC, Pellikka PA, Mullany CJ, Kvols LK. Outcome of cardiac surgery for carcinoid heart disease. J7 Am Coll Cardiol 1995; 25: 410-6.","journal-title":"J7 Am Coll Cardiol"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"68","DOI":"10.7326\/0003-4819-92-1-68","article-title":"Somatostatin inhibits diarrhea in carcinoid syndrome","volume":"92","author":"Dharmsathaphorn, K.; Sherwin, R.S.; Cataland, S.; Jaffe, B.; Dobbins, J.","year":"1980","unstructured":"Dharmsathaphorn K, Sherwin RS, Cataland S, Jaffe B, Dobbins J. Somatostatin inhibits diarrhea in carcinoid syndrome. Ann Intern Med 1980; 92: 68-9.","journal-title":"Ann Intern Med"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1749-6632.1994.tb17296.x","article-title":"Metastatic carcinoid tumours and the malignant carcinoid syndrome","volume":"733","author":"Kvols, L.K.","year":"1994","unstructured":"Kvols LK. Metastatic carcinoid tumours and the malignant carcinoid syndrome. Ann NY Acad Sci 1994; 733: 464-70.","journal-title":"Ann NY Acad Sci"},{"key":"ref_28","first-page":"1423","article-title":"Characterization of the somatostatin receptor subtype in a bronchial carcinoid tumor responsible for Cushing's syndrome","volume":"80","author":"Lefebvre, H.; Jegou, S.; Leroux, P.; Dero, M.; Vaudry, H.; Kuhn, J.M.","year":"1995","unstructured":"Lefebvre H, Jegou S, Leroux P, Dero M, Vaudry H, Kuhn JM. Characterization of the somatostatin receptor subtype in a bronchial carcinoid tumor responsible for Cushing's syndrome. J Clin Endocrinol Metab 1995; 80: 1423-8.","journal-title":"J Clin Endocrinol Metab"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1172\/JCI117090","article-title":"Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors","volume":"93","author":"Kubota, A.; Yamada, Y.; Kagimoto, S.","year":"1994","unstructured":"Kubota A, Yamada Y, Kagimoto S, et al. Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors. J Clin Invest 1994; 93: 1321-5.","journal-title":"J Clin Invest"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1056\/NEJM199601253340408","volume":"334","author":"Lamberts, S.W.J.; Van der Lely, A.; de Herder, W.W.; Octreotide, Hofland U.","year":"1996","unstructured":"Lamberts SWJ, Van der Lely A, de Herder WW, Hofland U. Octreotide. N Engl J Med 1996; 334: 246-54.","journal-title":"N Engl J Med"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/bja\/72.3.335","article-title":"Review of the anaesthetic management of 21 patients undergoing laparotomy for carcinoid syndrome","volume":"72","author":"Veall, G.R.Q.; Peacock, J.E.; Bax, N.D.S.; Reilly, C.S.","year":"1994","unstructured":"Veall GRQ, Peacock JE, Bax NDS, Reilly CS. Review of the anaesthetic management of 21 patients undergoing laparotomy for carcinoid syndrome. Br_J Anaesth 1994; 72: 335 - 41.","journal-title":"Br_J Anaesth"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2125.1994.tb04344.x","article-title":"Pharmacokinetic and pharmacodynamic properties of a long-acting formulation of the new somatostatin analogue, lanreotide, in normal healthy volunteers","volume":"38","author":"Kuhn, J.M.; Legrand, A.; Ruiz, J.M.; Obach, R.; De Ronzan, J.; Thomas, F.","year":"1994","unstructured":"Kuhn JM, Legrand A, Ruiz JM, Obach R, De Ronzan J, Thomas F. Pharmacokinetic and pharmacodynamic properties of a long-acting formulation of the new somatostatin analogue, lanreotide, in normal healthy volunteers. Br J Clin Pharmacol 1994; 38: 213-9.","journal-title":"Br J Clin Pharmacol"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0889-8529(18)30142-7","article-title":"The use of chemotherapy in the management of neuroendocrine tumors","volume":"22","author":"Oberg, K.","year":"1993","unstructured":"Oberg K. The use of chemotherapy in the management of neuroendocrine tumors. Endocrinol Metab Clin North Am 1993; 22: 941-52.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3109\/02841868909111217","article-title":"Medical treatment of neuroendocrine gut and pancreatic tumors","volume":"28","author":"Oberg, K.; Eriksson, B.","year":"1989","unstructured":"Oberg K, Eriksson B. Medical treatment of neuroendocrine gut and pancreatic tumors. Acta Oncol 1989; 28: 425-31.","journal-title":"Acta Oncol"},{"issue":"1","key":"ref_35","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1365-2141.1991.tb08125.x","article-title":"The role of interferons in the management of carcinoid tumours","volume":"79","author":"Oberg, K.; Eriksson, B.","year":"1991","unstructured":"Oberg K, Eriksson B. The role of interferons in the management of carcinoid tumours. Br J Haematol 1991; 79 (suppl 1): 74-7.","journal-title":"Br J Haematol"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0140-6736(90)91879-F","article-title":"Interferon-induced enhancement of 2'-, 5'-oligoadenylate synthase in mid-gut carcinoid tumours","volume":"336","author":"Grander, D.; Oberg, K.; Lundqvist, M.; Janson, E.T.; Eriksson, B.; Einhom, S.","year":"1990","unstructured":"Grander D, Oberg K, Lundqvist M, Janson ET, Eriksson B, Einhom S. Interferon-induced enhancement of 2'-, 5'-oligoadenylate synthase in mid-gut carcinoid tumours. Lancet 1990; 336: 337-40.","journal-title":"Lancet"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000201195","article-title":"Historical background and natural history of carcinoids","volume":"55","author":"Creutzfeld, W.","year":"1994","unstructured":"Creutzfeld W. Historical background and natural history of carcinoids. Digestion 1994; 55: 3-10.","journal-title":"Digestion"},{"key":"ref_38","first-page":"2803","article-title":"Neuroendocrine tumours of carcinoid variety","author":"Vinik, A.I.; Renar, I.P.","year":"1995","unstructured":"Vinik AI, Renar IP. Neuroendocrine tumours of carcinoid variety. In: De Grool L, ed. Endocronology, 3rd edn. Philadelphia: WB Saunders, 1995; pp 2803-4.","edition":"3rd edn"}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/73\/858\/207\/50220990\/postgradmedj-73-207.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/73\/858\/207\/50220990\/postgradmedj-73-207.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T16:01:54Z","timestamp":1738857714000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/73\/858\/207\/7042046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,4,1]]},"references-count":38,"journal-issue":{"issue":"858","published-online":{"date-parts":[[1997,4,1]]},"published-print":{"date-parts":[[1997,4,1]]}},"URL":"https:\/\/doi.org\/10.1136\/pgmj.73.858.207","relation":{},"ISSN":["0032-5473","1469-0756"],"issn-type":[{"type":"print","value":"0032-5473"},{"type":"electronic","value":"1469-0756"}],"subject":[],"published-other":{"date-parts":[[1997,4]]},"published":{"date-parts":[[1997,4,1]]}}}